These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 578628)

  • 1. Assessment of unconjugated oestradiol and progesterone serum levels throughout pregnancy in normal women and in women with hyperprolactinaemia, who conceived after bromocriptine treatment.
    Thomas CM; Corbey RS; Rolland R
    Acta Endocrinol (Copenh); 1977 Oct; 86(2):405-14. PubMed ID: 578628
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of hyperprolactinemic luteal insufficiency with bromocriptine.
    Andersen AN; Larsen JF; Eskildsen PC; Knoth M; Micic S; Svenstrup B; Nielsen J
    Acta Obstet Gynecol Scand; 1979; 58(4):379-83. PubMed ID: 525272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin changes in maternal plasma following termination by vacuum curettage and the effect of bromocriptine treatment on these changes.
    Ylikorkala O; Rönnberg L
    Br J Obstet Gynaecol; 1980 Oct; 87(10):911-5. PubMed ID: 7426491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of luteal phase inadequacy with bromocriptine.
    Saunders DM; Hunter JC; Haase HR; Wilson GR
    Obstet Gynecol; 1979 Mar; 53(3):287-9. PubMed ID: 424098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of prolactin in luteal inadequacy: treatment of hyperprolactinaemia with bromocriptine.
    Atasü T; Kösebay D; Aksu F
    Curr Med Res Opin; 1988; 11(1):56-63. PubMed ID: 3383612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of treatment with bromoergocryptine in functional infertility caused by corpus luteum insufficiency].
    Apró G; Godó G; Sas M
    Zentralbl Gynakol; 1983; 105(8):473-7. PubMed ID: 6868875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinaemia and female infertility.
    Godó G
    Acta Med Hung; 1984; 41(4):185-93. PubMed ID: 6440115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
    Prathibha D; Govardhani M; Krishna PT
    J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin and deficient luteal function.
    del Pozo E; Wyss H; Tollis G; Alcañiz J; Campana A; Naftolin F
    Obstet Gynecol; 1979 Mar; 53(3):282-6. PubMed ID: 424097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of hyperprolactinaemia after bromocriptine-induced pregnancy.
    Noble AD
    Lancet; 1979 May; 1(8125):1079-80. PubMed ID: 86795
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute changes in serum prolactin concentration have no effect on the secretion of progesterone, estradiol, or chorionic gonadotropin during early pregnancy.
    Ranta T; Lehtovirta P; Stenman UH; Laatikainen T; Seppälä M
    J Clin Endocrinol Metab; 1980 Sep; 51(3):544-7. PubMed ID: 7410533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of bromocriptine in unexplained primary infertility: a double-blind controlled trial.
    Wright CS; Steele SJ; Jacobs HS
    Br Med J; 1979 Apr; 1(6170):1037-9. PubMed ID: 376036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin levels and bromocriptine treatment of short luteal phase.
    Lehtovirta P; Arjomaa P; Ranta T; Laatikainen T; Hirvonen E; Seppälä M
    Int J Fertil; 1979; 24(1):57-60. PubMed ID: 37181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of hyperprolactinaemia after bromocriptine-induced pregnancy.
    Cowden EA; Thomson JA
    Lancet; 1979 Mar; 1(8116):613. PubMed ID: 85202
    [No Abstract]   [Full Text] [Related]  

  • 16. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME; Alborzi S; Jahromi BN
    Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Borderline hyperprolactinemia in infertile women: evaluation of the prolactin response to thyrotropin releasing hormone and double-blind placebo-controlled treatment with bromocriptine.
    Glazener CM; Kelly NJ; Hull MG
    Gynecol Endocrinol; 1987 Dec; 1(4):373-8. PubMed ID: 3140587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin levels in pregnancy: comparison of normal subjects with patients having micro- or macroadenomas after early bromocriptine withdrawal.
    Woodhouse NJ; Niles N; McDonald D; McCorkell S
    Horm Res; 1985; 21(1):1-9. PubMed ID: 3972334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum prolactin and bromocriptine treatment in female infertility.
    Selander K; Saarikoski S; Pystynen P
    Reproduccion; 1981; 5(3):135-40. PubMed ID: 7286377
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
    Parra A; Crespo G; Coria I; Espinosa de los Monteros A
    Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.